Skip to main content
SpringerLink
Log in

Psychotropic Drugs and the Perinatal Period

  • Chapter
Joint Care of Parents and Infants in Perinatal Psychiatry

Abstract

The prescription of psychotropic drugs during pregnancy is always challenging. Clinicians must weigh the risk of a maternal relapse should treatment be interrupted or modified against the teratogenic or fetotoxic risk of antenatal exposure to psychotropic drugs. Women must be informed of the potential influence on the pregnancy and the course of their disorder and consider whether the benefits outweigh the risk. The mother’s ability postpartum to care for and interact with the infant appropriately is an important consideration. The management of these pregnancies must be nested in a multidisciplinary network, to allow antenatal implementation of specific types of care in accordance with local or national perinatal mental health policies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aagaard L, Hansen EH (2010) Adverse drug reactions from psychotropic medicines in the paediatric population: analysis of reports to the Danish Medicines Agency over a decade. BMC Res Notes 3:176

    Article  PubMed Central  PubMed  Google Scholar 

  • Alsaad AM, Chaudhry SA, Koren G (2015) First trimester exposure to topiramate and the risk of oral clefts in the offspring: a systematic review and meta-analysis. Reprod Toxicol 20:45–50. doi:10.1016/j.reprotox.2015.03.003

    Article  Google Scholar 

  • Anderson EL, Reti IM (2009) ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosom Med 71:235–242

    Article  PubMed  Google Scholar 

  • ANSM (2013) National Security Agency of Medicines and Health Products. http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Bromocriptine-Parlodel-R-et-Bromocriptine-Zentiva-R-le-rapport-benefice-risque-n-est-plus-favorable-dans-l-inhibition-de-la-lactation-Point-d-information

  • Arkilo D, Hanna J, Dickens D (2015) Pregnancy and neurodevelopmental outcomes with in-utero antiepileptic agent exposure. A pilot study. Eur J Paediatr Neurol 19:37–40. doi:10.1016/j.ejpn.2014.09.006

    Article  PubMed  Google Scholar 

  • Baker GA, Bromley RL, Briggs M et al. (2015) IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology 84:382–390 doi:10.1212/WNL.0000000000001182

    Google Scholar 

  • Barlow J, Bennett C, Midgley N et al (2015) Parent-infant psychotherapy for improving parental and infant mental health. Cochrane Database Syst Rev 1:CD010534

    Google Scholar 

  • Bergink V, Kushner SA (2014) Lithium during pregnancy. Am J Psychiatry 171:712–715. doi:10.1176/appi.ajp.2014.14030409

    Article  PubMed  Google Scholar 

  • Bogen DL, Sit D, Genovese A et al (2012) Three cases of lithium exposure and exclusive breastfeeding. Arch Womens Ment Health 15:69–72

    Article  PubMed Central  PubMed  Google Scholar 

  • Burt VK, Rasgon N (2004) Special considerations in treating bipolar disorder in women. Bipolar Disord 6:2–13

    Article  CAS  PubMed  Google Scholar 

  • Calderon-Margalit R, Qiu C, Ornoy A et al (2009) Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am J Obstet Gynecol 201(579):e571–e578

    Google Scholar 

  • Campbell E, Kennedy F, Russell A (2014) Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 85:1029–1034. doi:10.1136/jnnp-2013-306318

    Article  CAS  PubMed  Google Scholar 

  • Casper RC (2015) Use of selective serotonin reuptake inhibitor antidepressants in pregnancy does carry risks, but the risks are small. J Nerv Ment Dis 203(3):167–169

    Article  PubMed  Google Scholar 

  • Chambers CD, Hernandez-Diaz S, Van Marter LJ (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6):579–587

    Article  CAS  PubMed  Google Scholar 

  • Clark CT, Klein AM, Perel JM et al (2013) Lamotrigine dosing for pregnant patients with bipolar disorder. Am J Psychiatry 170:1240–1247. doi:10.1176/appi.ajp.2013.13010006

    Article  PubMed Central  PubMed  Google Scholar 

  • Diav-Citrin O, Shechtman S, Tahover E (2014) Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry 171:785–794. doi:10.1176/appi.ajp.2014.12111402

    Article  PubMed  Google Scholar 

  • Einarson TR, Einarson A (2005) Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol Drug Saf 14:823–827

    Article  CAS  PubMed  Google Scholar 

  • Enato E, Moretti M, Koren G (2011) The fetal safety of benzodiazepines: an updated meta-analysis. J Obstet Gynaecol Can 33:46–48

    PubMed  Google Scholar 

  • Ennis ZN, Damkier P (2015) Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review. Basic Clin Pharmacol Toxicol 116(4):315–320. doi:10.1111/bcpt.12372

    Article  CAS  PubMed  Google Scholar 

  • Eriksson K, Viinikainen K, Mönkkönen A et al (2005) Children exposed to valproate in utero – population based evaluation of risks and confounding factors for long-term neurocognitive development. Epilepsy Res 65(3):189–200

    Article  CAS  PubMed  Google Scholar 

  • Ernst CL, Goldberg JF (2002) The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics. J Clin Psychiatry 63(Suppl 4):42–55

    CAS  PubMed  Google Scholar 

  • Gaffield ME, Culwell KR, Lee CR (2011) The use of hormonal contraception among women taking anticonvulsant therapy. Contraception 83:16–29

    Article  CAS  PubMed  Google Scholar 

  • Galbally M, Snellen M, Walker S et al (2010) Management of antipsychotic and mood stabilizer medication in pregnancy: recommendations for antenatal care. Aust N Z J Psychiatry 44:99–108

    Article  PubMed  Google Scholar 

  • Galbally M, Snellen M, Power J (2014) Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects. Ther Adv Drug Saf 5:100–109. doi:10.1177/2042098614522682

    Article  PubMed Central  PubMed  Google Scholar 

  • Gentile S (2004) Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 38:1265–1271

    Article  CAS  PubMed  Google Scholar 

  • Gentile S (2010a) On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome. CNS Spectr 15(3):167–185

    PubMed  Google Scholar 

  • Gentile S (2010b) Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull 36:518–544

    Article  PubMed Central  PubMed  Google Scholar 

  • Gentile S (2015) Prenatal antidepressant exposure and the risk of autism spectrum diosrders in children. Are we looking at the fall of Gods ? J Affect Disord 6:132–137

    Article  Google Scholar 

  • Giles JJ, Bannigan JG (2006) Teratogenic and developmental effects of lithium. Curr Pharm Des 12:1531–1541

    Article  CAS  PubMed  Google Scholar 

  • Gedzelman E, Kimford J, Meador MD (2012) Antiepileptic drugs in women with epilepsy during pregnancy. Ther Adv Drug Safe 3(2):71–87

    Article  Google Scholar 

  • Grigoriadis S, VonderPorten EH, Mamisashvili L et al (2013) Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry 74(4):e293–e308. doi:10.4088/JCP.12r07966

    Article  CAS  PubMed  Google Scholar 

  • Hale TW, Rowe HE (2014) Medication and mother milk. Hale Publishing, Plano, TX, LP. 978-1-9398473-8-6.

    Google Scholar 

  • Hanley GE, Brain U, Oberlander T (2015) Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behaviour. Pediatr Res 21. doi:10.1038/pr.2015.77.

    Google Scholar 

  • Hernández-Díaz S, Smith CR, Shen A et al (2012) Comparative safety of antiepileptic drugs during pregnancy; North American AED Pregnancy Registry. Neurology 78:1692–1699. doi:10.1212/WNL.0b013e3182574f39

    Article  PubMed  Google Scholar 

  • Huybrechts KF, Palmsten K, Avorn J, Cohen LS, Holmes LB, Franklin JM, Mogun H, Levin R, Kowal M, Setoguchi S, Hernández-Díaz S (2014) Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 370:2397–2407. doi:10.1056/NEJMoa1312828.

    Google Scholar 

  • Impastato DJ, Gabriel AR, Lardaro HH (1964) Electric and insulin shock therapy during pregnancy. Dis Nerv Syst 25:542–546

    CAS  PubMed  Google Scholar 

  • Jimenez-Solem E (2014) Exposure to antidepressants during pregnancy-prevalences and outcomes. Dan Med J 61(9):B4916

    PubMed  Google Scholar 

  • Kieviet N, Dolman KM, Honig A (2013) The use of psychotropic medication during pregnancy: how about the newborn? Neuropsychiatr Dis Treat 9:1257–1266

    Article  PubMed Central  PubMed  Google Scholar 

  • Mcknight RF, Adida M, Budge K et al (2012) Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379:721–728

    Article  CAS  PubMed  Google Scholar 

  • Meador KJ, Baker GA, Browning N et al (2014) Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr 168:729–736. doi:10.1001/jamapediatrics.2014.118

    Article  PubMed Central  PubMed  Google Scholar 

  • Miller WH Jr, Bloom JD, Resnick MP (1992) Prenatal care for pregnant chronic mentally ill patients. Hosp Community Psychiatry 43:942–943

    PubMed  Google Scholar 

  • Misdrahi D, Chalard R, Verdoux H (2006) Postpartum mania induced by Bromocriptine: a case report. J Gynecol Obstet Biol Reprod 35:79–81

    Article  CAS  Google Scholar 

  • Moretti ME (2009) Psychotropic drugs in lactation – Motherisk update 2008. Can J Clin Pharmacol 16:e49–e57

    PubMed  Google Scholar 

  • Moses-Kolko EL, Bogen D, Perel J et al (2005) Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293:2372–2383

    Article  CAS  PubMed  Google Scholar 

  • Newport DJ, Viguera AC, Beach AJ et al (2005) Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy. Am J Psychiatry 162:2162–2170

    Article  PubMed  Google Scholar 

  • NICE guidelines (2014) Antenatal and postnatal mental health: clinical management and service guidance [CG192]. https://www.nice.org.uk/guidance/cg192#

    Google Scholar 

  • Newham JJ, Thomas SH, Macritchie K et al (2008) Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry 192:333–337

    Article  PubMed  Google Scholar 

  • Nulman I (2014) The effects of the new antipsychotic medications on mothers and babies. J Popul Ther Clin Pharmacol 21:e542–e547

    PubMed  Google Scholar 

  • Odsbu I, Skurtveit S, Selmer R et al (2015) Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age. Eur J Clin Pharmacol 71:283–291. doi:10.1007/s00228-014-1797-4

    Article  CAS  PubMed  Google Scholar 

  • Okun ML, Ebert R, Saini B (2015) A review of sleep-promoting medications used in pregnancy. Am J Obstet Gynecol 212:428–441. doi:10.1016/j.ajog.2014.10.1106

    Article  CAS  PubMed  Google Scholar 

  • Pedersen LH, Henriksen TB, Vestergaard M et al (2009) Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 339:b3569

    Article  PubMed Central  PubMed  Google Scholar 

  • Pinkofsky HB (2000) Effects of antipsychotics on the unborn child: what is known and how should this influence prescribing? Paediatr Drugs 2:83–90

    Article  CAS  PubMed  Google Scholar 

  • Reis M, Kallen B (2008) Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 28:279–288

    Article  CAS  PubMed  Google Scholar 

  • Ross LE, Grigoriadis S, Mamisashvili L et al (2013) Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry 70(4):436–443

    Article  PubMed  Google Scholar 

  • Schou M, Goldfield MD, Weinstein MR et al (1973) Lithium and pregnancy. I. Report from the Register of Lithium Babies. BMJ 2:135–136

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Sie SD, Wennink JM, Van Driel JJ et al (2012) Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation. Arch Dis Child Fetal Neonatal Ed 97:F472–F476

    CAS  PubMed  Google Scholar 

  • Santucci AK, Singer LT, Wisniewski SR et al (2014) Impact of prenatal exposure to serotonin reuptake inhibitors or maternal major depressive disorder on infant developmental outcomes. J Clin Psychiatry 75:1088–1095. doi:10.4088/JCP.13m08902

    Article  PubMed  Google Scholar 

  • Stika L, Elisová K, Honzáková L et al (1990) Effects of drug administration in pregnancy on children’s school behaviour. Pharm Weekbl Sci 12(6):252–255

    Article  CAS  PubMed  Google Scholar 

  • Sutter-Dallay AL, Bales M, Pambrun E et al (2015) Impact of prenatal exposure to psychotropic drugs on neonatal outcome in infants of mothers with serious psychiatric illnesses. J Clin Psychiatry 76(7):967–73. doi: 10.4088/JCP.14m09070

    Google Scholar 

  • Taylor LG, Thelus Jean R, Gordon G, Fram D, Coster T (2015) Development of a mother-child database for drug exposure and adverse event detection in the Military Health System. Int J Epidemiol 14. Pii: dyv030

    Google Scholar 

  • Van Der Lugt NM, Van De Maat JS, Van Kamp IL et al (2012) Fetal, neonatal and developmental outcomes of lithium-exposed pregnancies. Early Hum Dev 88:375–378

    Article  PubMed  Google Scholar 

  • Van Der Pol MC, Hadders-Algra M, Huisjes HJ et al (1991) Antiepileptic medication in pregnancy: late effects on the children’s central nervous system development. Am J Obstet Gynecol 164:121–128

    Article  PubMed  Google Scholar 

  • Veiby G, Daltveit AK, Engelsen BA et al (2014) Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J Neurol 261:579–588. doi:10.1007/s00415-013-7239-x

    Article  CAS  PubMed  Google Scholar 

  • Veiby G, Bjørk M, Engelsen BA et al (2015) Epilepsy and recommendations for breastfeeding. Seizure. pii: S1059-1311(15)00041-2. doi:10.1016/j.seizure.2015.02.013

    Google Scholar 

  • Viguera AC, Nonacs R, Cohen LS et al (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 157:179–184

    Article  CAS  PubMed  Google Scholar 

  • Viguera AC, Whitfield T, Baldessarini RJ et al (2007) Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 164:1817–1824; quiz 1923

    Article  PubMed  Google Scholar 

  • Williams M, Wooltorton E (2005) Paroxetine (Paxil) and congenital malformations. CMAJ Can Med Assoc J Journal de l’Association Médicale Canadienne 173:1320–1321

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Perinatal Psychiatry Network, University Department of Adult Psychiatry, Centre Hospitalier Choperrens and INSERM U657, Bordeaux University, Bordeaux, France

    Anne-Laure Sutter-Dallay MD, PhD

  2. Center for Gender Research and Early Detection, Psychiatric University Clinics Basel, Kornhausgasse 7, Basel, CH-4051, Switzerland

    Anita Riecher-Rössler MD PhD

Authors
  1. Anne-Laure Sutter-Dallay MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anita Riecher-Rössler MD PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne-Laure Sutter-Dallay MD, PhD .

Editor information

Editors and Affiliations

  1. Perinatal Psychiatry Network,University Department of Adult Psychiatry , Centre Hospitalier Choperrens and INSERM U657,Bordeaux University, Bordeaux, France

    Anne-Laure Sutter-Dallay

  2. Obstetrical Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics, Sorbonne Paris Cité, DHU Risks in Pregnancy,Paris Descartes University, Paris, France

    Nine M-C Glangeaud-Freudenthal

  3. Department of Child & Adolescent Psychiatry, Hôpital Bichat-Claude Bernard,Paris Diderot University, Paris, France

    Antoine Guedeney

  4. Center for Gender Research and Early Detection, Psychiatric University Clinics Basel, Basel, Switzerland

    Anita Riecher-Rössler

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Sutter-Dallay, AL., Riecher-Rössler, A. (2016). Psychotropic Drugs and the Perinatal Period. In: Sutter-Dallay, AL., Glangeaud-Freudenthal, NC., Guedeney, A., Riecher-Rössler, A. (eds) Joint Care of Parents and Infants in Perinatal Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-21557-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-21557-0_5

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-21556-3

  • Online ISBN: 978-3-319-21557-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation